Karan R Kumar1, David A Clark2, Evan M Kim2, Jasmine D Perry2, Kaylyn Wright2, Sheikisha A Thomas2, Elizabeth J Thompson3, Rachel G Greenberg1, P Brian Smith1, Daniel K Benjamin1, Matthew M Laughon4, Reese H Clark5, Christoph P Hornik6. 1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Pediatrics, Duke University School of Medicine, Durham, NC. 2. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC. 3. Department of Pediatrics, Duke University School of Medicine, Durham, NC. 4. Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC. 5. Pediatrix-Obstetrix Center for Research and Education, Sunrise, FL. 6. Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Pediatrics, Duke University School of Medicine, Durham, NC. Electronic address: christoph.hornik@duke.edu.
Abstract
OBJECTIVE: To evaluate the association between the presence of an atrial septal defect (ASD) and the odds of developing bronchopulmonary dysplasia (BPD) in premature infants. STUDY DESIGN: We identified a cohort of infants that underwent at least one echocardiogram assessment, birth weight 501-1249 g, and gestational age 23-30 weeks discharged from the neonatal intensive care unit from 2004 to 2016. We used a BPD risk estimator to calculate the predicted risk of developing BPD at 6 postnatal ages within the first 28 days of life. We examined the association between the presence of an ASD and the development of BPD using 2 multivariable logistic regression models for each BPD risk severity on each postnatal day. The first model adjusted for predicted BPD risk and the second added therapeutic interventions for BPD. RESULTS: Of 20 496 infants from 228 NICUs who met inclusion criteria, 8892 (43%) were diagnosed with BPD and 1314 (6%) had an ASD. BPD was present in 48% of infants with an ASD and 43% of infants without an ASD. In infants with an ASD, the OR of developing BPD was higher after adjusting for predicted risk of BPD plus therapeutic interventions, regardless of postnatal age or predicted BPD risk severity. CONCLUSIONS: The presence of an ASD was associated with an increased odds of BPD in this cohort. Future trials should consider ASD as a potentially modifiable risk factor in this vulnerable population.
OBJECTIVE: To evaluate the association between the presence of an atrial septal defect (ASD) and the odds of developing bronchopulmonary dysplasia (BPD) in premature infants. STUDY DESIGN: We identified a cohort of infants that underwent at least one echocardiogram assessment, birth weight 501-1249 g, and gestational age 23-30 weeks discharged from the neonatal intensive care unit from 2004 to 2016. We used a BPD risk estimator to calculate the predicted risk of developing BPD at 6 postnatal ages within the first 28 days of life. We examined the association between the presence of an ASD and the development of BPD using 2 multivariable logistic regression models for each BPD risk severity on each postnatal day. The first model adjusted for predicted BPD risk and the second added therapeutic interventions for BPD. RESULTS: Of 20 496 infants from 228 NICUs who met inclusion criteria, 8892 (43%) were diagnosed with BPD and 1314 (6%) had an ASD. BPD was present in 48% of infants with an ASD and 43% of infants without an ASD. In infants with an ASD, the OR of developing BPD was higher after adjusting for predicted risk of BPD plus therapeutic interventions, regardless of postnatal age or predicted BPD risk severity. CONCLUSIONS: The presence of an ASD was associated with an increased odds of BPD in this cohort. Future trials should consider ASD as a potentially modifiable risk factor in this vulnerable population.
Authors: A F Broccard; J R Hotchkiss; N Kuwayama; D A Olson; S Jamal; D O Wangensteen; J J Marini Journal: Am J Respir Crit Care Med Date: 1998-06 Impact factor: 21.405
Authors: Amy M Wood; Ralf J Holzer; Karen M Texter; Sharon L Hill; Alfred L Gest; Stephen E Welty; John P Cheatham; Andrew R Yates Journal: Congenit Heart Dis Date: 2011-07-01 Impact factor: 2.007
Authors: Astrid Lammers; Alfred Hager; Andreas Eicken; Rüdiger Lange; Michael Hauser; John Hess Journal: J Thorac Cardiovasc Surg Date: 2005-06 Impact factor: 5.209
Authors: Matthew M Laughon; John C Langer; Carl L Bose; P Brian Smith; Namasivayam Ambalavanan; Kathleen A Kennedy; Barbara J Stoll; Susie Buchter; Abbot R Laptook; Richard A Ehrenkranz; C Michael Cotten; Deanne E Wilson-Costello; Seetha Shankaran; Krisa P Van Meurs; Alexis S Davis; Marie G Gantz; Neil N Finer; Bradley A Yoder; Roger G Faix; Waldemar A Carlo; Kurt R Schibler; Nancy S Newman; Wade Rich; Abhik Das; Rosemary D Higgins; Michele C Walsh Journal: Am J Respir Crit Care Med Date: 2011-03-04 Impact factor: 21.405
Authors: Elizabeth J Short; H Lester Kirchner; George R Asaad; Sarah E Fulton; Barbara A Lewis; Nancy Klein; Sheri Eisengart; Jill Baley; Carolyn Kercsmar; Meeyoung O Min; Lynn T Singer Journal: Arch Pediatr Adolesc Med Date: 2007-11
Authors: Andrea Trembath; Christoph P Hornik; Reese Clark; P Brian Smith; Julie Daniels; Matthew Laughon Journal: J Pediatr Date: 2013-06-12 Impact factor: 4.406
Authors: Barbara J Stoll; Nellie I Hansen; Edward F Bell; Michele C Walsh; Waldemar A Carlo; Seetha Shankaran; Abbot R Laptook; Pablo J Sánchez; Krisa P Van Meurs; Myra Wyckoff; Abhik Das; Ellen C Hale; M Bethany Ball; Nancy S Newman; Kurt Schibler; Brenda B Poindexter; Kathleen A Kennedy; C Michael Cotten; Kristi L Watterberg; Carl T D'Angio; Sara B DeMauro; William E Truog; Uday Devaskar; Rosemary D Higgins Journal: JAMA Date: 2015-09-08 Impact factor: 56.272
Authors: Rachel G Greenberg; Sreepriya Gayam; Destiny Savage; Andrew Tong; Daniel Gorham; Ari Sholomon; Reese H Clark; Daniel K Benjamin; Matthew Laughon; P Brian Smith Journal: J Pediatr Date: 2018-12-20 Impact factor: 6.314